Seroprevalence Investigation of Hepatitis B and Hepatitis B Core Antigen in Oncology Patients

AKDEMİR KALKAN İ., Demirci A., ÇINAR G., ÇELEN M. K.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, sa.3, ss.110-113, 2020 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/vhd.galenos.2020.2019.0036
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.110-113
  • Anahtar Kelimeler: Hepatitis B reactivation, oncology, immunosuppressive treatments, prophylactic antiviral treatments, REACTIVATION
  • Ankara Üniversitesi Adresli: Evet

Özet

Objectives: Hepatitis B virus (HBV) affects a significant part of society and is characterized by high mortality and morbidity. Hepatitis B affects approximately 350 million people worldwide, many of whom are chronic patients. Especially being under immunosuppressive therapy is a risk factor for the reactivation of the disease. The aim of this study was to investigate the seroprevalence of HB in oncology patients.